Supriya Lifescience

689.55
-5.15
(-0.74%)
Market Cap
5,549.69 Cr
EPS
14.80
PE Ratio
29.72
Dividend Yield
0.14 %
Industry
Healthcare
52 Week High
842.00
52 Week Low
351.55
PB Ratio
5.60
Debt to Equity
0.02
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,669.80
#1 4,00,640.95
35.21
#1 49,887.20
12.06
#1 9,648
-18.99
44.63
6,534.00
1,73,457.17
80.34
8,184.00
0.89
1,600
23.05
62.67
1,492.50
1,20,536.53
22.82
26,520.70
14.17
4,155
30.28
51.33
1,311.60
1,09,447.17
#1 19.03
28,905.40
12.36
5,578
21.14
76.09
3,147.80
1,06,535.86
55.19
10,785.70
11.59
1,656
10.91
41.99
2,352.00
97,038.47
49.05
10,615.60
19.57
1,942
-10.91
38.59
949.70
95,562.04
20.59
19,831.50
13.82
3,831
-0.19
70.27
1,991.00
90,897.30
27.77
20,141.50
#1 19.94
1,936
#1 112.49
49.75
31,860.00
67,700.28
47.62
6,097.20
10.80
1,201
27.83
64.21
1,152.50
66,937.39
19.49
29,559.20
17.55
3,169
-0.50
46.75

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
23.51 %
Net Income Growth
32.48 %
Cash Flow Change
78.13 %
ROE
13.70 %
ROCE
13.74 %
EBITDA Margin (Avg.)
7.41 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
140
172
191
222
286
323
396
538
470
581
706
Expenses
121
150
166
191
213
213
218
316
332
397
436
EBITDA
20
22
25
31
73
110
178
222
138
184
271
Operating Profit %
12 %
12 %
9 %
10 %
23 %
32 %
44 %
40 %
28 %
30 %
38 %
Depreciation
3
4
5
5
5
6
7
10
12
16
21
Interest
7
10
12
11
10
7
4
4
3
2
2
Profit Before Tax
10
8
8
15
57
96
167
207
124
166
249
Tax
2
2
2
6
18
23
44
55
34
47
57
Net Profit
8
6
6
9
39
73
124
152
90
119
188
EPS in ₹
16.82
3.89
3.87
1.19
5.39
10.02
16.89
18.86
11.16
14.80
23.40

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
176
231
241
245
253
336
446
735
820
921
Fixed Assets
61
76
89
91
85
99
100
190
262
310
Current Assets
103
129
115
120
133
196
266
498
465
398
Capital Work in Progress
11
25
36
34
35
40
79
43
68
149
Investments
0
0
0
0
0
0
0
0
25
64
Other Assets
104
131
117
120
133
197
267
502
466
399
Total Liabilities
176
231
241
245
253
336
446
735
820
921
Current Liabilities
115
150
144
146
135
155
146
100
96
77
Non Current Liabilities
23
39
51
45
24
32
31
19
25
29
Total Equity
37
42
46
55
94
149
269
616
700
815
Reserve & Surplus
33
26
31
40
79
134
254
600
683
799
Share Capital
5
15
15
15
15
15
15
16
16
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
2
-2
3
4
62
15
139
-70
-83
Investing Activities
-23
-33
-27
-5
5
-25
-47
-60
-124
-174
Operating Activities
-6
14
27
28
49
117
76
49
64
113
Financing Activities
30
21
-2
-20
-50
-29
-15
150
-10
-22

Share Holding

% Holding
May 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
99.98 %
68.24 %
68.24 %
68.24 %
68.24 %
68.24 %
68.28 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.34 %
0.00 %
5.36 %
4.95 %
6.03 %
6.52 %
7.19 %
DIIs
0.00 %
5.20 %
4.72 %
7.27 %
6.23 %
7.89 %
7.65 %
7.55 %
7.17 %
3.85 %
5.30 %
5.48 %
5.45 %
4.92 %
4.26 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
8.25 %
12.73 %
12.52 %
13.40 %
15.07 %
15.54 %
15.39 %
16.10 %
17.50 %
17.06 %
17.19 %
0.00 %
16.28 %
16.40 %
Others
0.02 %
18.30 %
14.31 %
11.97 %
12.13 %
8.80 %
8.53 %
8.76 %
3.09 %
10.35 %
3.98 %
4.08 %
20.23 %
3.98 %
3.85 %
No of Share Holders
7
50,506
82,578
86,853
94,594
96,998
95,605
93,478
92,991
95,929
87,980
89,621
85,328
89,394
91,051

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.54 0.6 0.6 0.8 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.11 0.32 0.18 0.11 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 701.60 742.45
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jan 2025 669.40 730.35
28 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2024 555.10 547.30
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 627.75 588.85
21 Sept 2024 DIVIDEND Dividend
₹ 0.80 /share
20 Sept 2024 360.75 630.75
15 Sept 2023 DIVIDEND Dividend
₹ 0.60 /share
15 Sept 2023 257.55 292.40
02 Sept 2022 DIVIDEND Dividend
₹ 0.60 /share
01 Sept 2022 355.25 355.05

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript5 days ago
Compliances-Reg.24(A)-Annual Secretarial Compliance8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome8 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release8 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation9 days ago
Announcement under Regulation 30 (LODR)-Dividend Updates9 days ago
Appointment Of Secretarial Auditor For Term Of Five (5) Consecutive Years9 days ago
Corporate Action-Board to consider Dividend9 days ago
Audited Financial Result For Quarter And Year Ended On March 31 20259 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On May 27 20259 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Year Ended March 31 2025 And Recommend Dividend If Any On The Equity Shares Of The Company For The Financial Year Ended March 31 2025May 20, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 28, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 01, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 25, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 17, 2025
Details Of Key Managerial Personnel Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 10, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 10, 2025
Appointment of Company Secretary and Compliance OfficerMar 10, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held To Consider Appointment Of Company Secretary And Compliance Officer Of The Company.Mar 10, 2025
Board Meeting Intimation for Appointment Of Company Secretary And Compliance Officer Of The CompanyMar 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 01, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 27, 2025
Audio Recording Of Earnings CallJan 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Jan 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 25, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 24, 2025
Integrated Filing (Financial)Jan 24, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJan 24, 2025
Details Of Key Managerial Personnel Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 24, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJan 24, 2025
Unaudited Financial Results For The Quarter And Nine Month Ended December 31 2024Jan 24, 2025
Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 17, 2025
Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 16, 2025

Technical Indicators

RSI(14)
Neutral
47.09
ATR(14)
Less Volatile
28.46
STOCH(9,6)
Oversold
19.97
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-2.42
ADX(14)
Weak Trend
17.15
UO(9)
Bullish
28.67
ROC(12)
Downtrend And Accelerating
-2.81
WillR(14)
Oversold
-96.06

Mutual Fund Holdings

Funding HouseNo of SharesCurrent Holding %1M Change %3M Change %Month
Quantum Small Cap Fund Direct - Growth
46999
2.64%
-0.55%
-0.22%
Apr 2025
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
41203
0.83%
-0.44%
-0.23%
Apr 2025
ITI Pharma and Healthcare Fund Direct - Growth
45159
1.33%
-0.38%
0.14%
Apr 2025
ITI Large & Mid Cap Fund Direct-Growth
215951
1.73%
-0.30%
-0.07%
Apr 2025
ITI ELSS Tax Saver Fund Direct - Growth
91519
1.53%
-0.25%
-0.06%
Apr 2025
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
75246
0.25%
-0.04%
0.12%
Apr 2025
Bandhan BSE Healthcare Index Fund Direct-Growth
367
0.13%
-0.02%
-0.01%
Apr 2025
Groww Nifty Total Market Index Fund Direct - Growth
382
0.01%
0.00%
0.00%
Apr 2025
ITI Value Fund Direct - Growth
0
0.00%
0.00%
0.00%
Apr 2025
Mirae Asset Nifty Total Market Index Fund Direct-Growth
53
0.01%
0.00%
0.00%
Apr 2025
Angel One Nifty Total Market Index Fund Direct - Growth
46
0.01%
0.00%
0.01%
Apr 2025
Bandhan Nifty Total Market Index Fund Direct-Growth
51
0.01%
0.00%
0.01%
Apr 2025
Samco Multi Cap Fund Direct-Growth
0
0.00%
0.00%
0.00%
Apr 2025
Samco Special Opportunities Fund Direct - Growth
0
0.00%
0.00%
-2.38%
Apr 2025